inmd fact sheet april

Upload: matt

Post on 08-Apr-2018

214 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/7/2019 INMD Fact Sheet April

    1/2

    0

    50

    100

    150

    200

    250

    2006 2007 2008 2009 2010

    DivisionalOverview:

    TheAttainFertilityCentersdivision iscomprisedof14partner fertility centers with 66 locations and 87

    physiciansandscientists that provide the full range of

    fertility treatment services. The division also has 28

    affiliate fertility centers with 66 locations that offer

    IntegraMeds Attain IVF Program suite of fertility

    treatmentfinancingsolutions.

    The Vein Clinics division was formed on August 2007withthepurchaseofVeinClinicsofAmerica(VCA).The

    VeinClinicsdivisionprovidesbusinessandmanagement

    services to a network of 44 clinics across 14 states

    specializing in the treatment of vein disease and

    disorders.

    IntegraMed also supports its operating divisions with

    shared services that can be leveraged across the

    operations. Included in the shared services

    infrastructure are information systems, finance and

    administration, human resources, legal services and

    investorrelations.

    LeadershipTeam:

    JayHigham President/CEO:Architectofdiversificationstrategy,14yearswithINMD

    AndrewMintz EVP/President,AttainFertilityCenteDan Doman President,VeinClinicsDivision leading

    currentexpansionandorganicgrowthstrategy

    TimSheehan VPFinance&InterimCFOScott Soifer EVP/CAO:Hasledhealthcaremarketing

    andstrategyactivitiesforover18years

    IntegraMedAmerica,Inc.Nasdaq:INMInvestorFactShee

    April20

    CorporateProfile:IntegraMedAmerica isa leader indeveloping,marketingandmanagingspecialtyoutpatienthealthcare facilitiwithacurrent focuson the fertility and vein care markets. IntegraMed supports its fertilityprovidernetwowithclinicalandbusinessinformationsystems,marketingandsales,facilitiesandoperationsmanagement,finan

    and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financprograms. IntegraMedprovidesthesameservicestosupportthegrowthand successofitsveinclinics.

    InvestorInformation:NorbertoAjaorDavidCollins,Jaffoni&Collins,[email protected]

    RecentEvents:January 2011: Acquired NorthwestCenter for ReproductSciencesandwillmergeitinto INMDs Seattleoperations.

    February 2011: Announced 2010 Revenue Rose 12%$243M;NetIncomeRose5%to$4.7M

    BusinessPerformance:

    14%RevenueCAG

    R

    RevenueMixContributionMix

  • 8/7/2019 INMD Fact Sheet April

    2/2

    MarketCap(3/31/11) $117M

    Enterprise

    Value

    (3/31/11) $86

    MEBITDA(ttm) $17M

    EV/EBITDA(ttm) 5.

    TrailingP/E(ttm) 25.

    Price/Sales(ttm) 0.

    Price/Book(mrq) 1.

    SafeHarbor:Statementscontainedinthispresentationthatarenotbasedonhistoricalfact,includingstatementsconcerningfutureresults, performan

    expectationsandexpansionofIntegraMedAmericaareforwardlookingstatements.Actualresultsmaydiffermateriallyfromthestatementsmadea

    result of various factors including, but not limited to, the risks associated with the Companys ability to finance future growth; the loss of signific

    businessservicescontract(s);profitabilityatfertilityandveincaredivisionsservicedbyIntegraMedAmerica;changesininsurancecoverage,governm

    lawsandregulationsregardinghealthcareormanagedcarecontracting;andotherrisks, includingthose identifiedintheCompanysmostrecentFo

    10Kand inotherdocuments filedbytheCompanywiththeU.S.SecuritiesandExchangeCommission. IntegraMeddoesnot assumeanyobligation

    updateanyforwardlookingstatementsorotherinformationcontainedinthispresentation.

    IntegraMedAmerica,Inc.Nasdaq:INMInvestorFactShee

    April20

    Revenues:

    AttainFertilityCenters 182,443$ 166,135$

    VeinClinics 60,726 50,625

    TotalRevenues 243,169 216,760

    OperatingIncome:

    FertilityCenters 17,725 16,790

    VeinClinics 3,491 4,100

    TotalContribution 21,216 20,890

    G&AExpenses 12,668 12,155

    NetInterestExpense 695 910

    IncomeBeforeIncomeTaxes 7,853 7,825

    IncomeTaxes 3,128 3,331

    NetIncome 4,725$ 4,494$

    DilutedEPS 0.41$ 0.51$

    DilutedShares 11,429 8,834

    Cashandcashequivalents 50,183$ 28,865$

    Totalcurrentassets 69,654$ 46,365$

    Totalassets 148,655$ 124,309$

    Longtermdebt 10,908$ 14,849$

    TotalShareholders Equity 83,520$ 58,193$

    (Allamountsinthousands,exceptpersharedata)

    ValuationMeasures:

    HistoricalStockPricesandVolume:

    KeyTradingStatistics:

    Dougherty&Co. BrooksONeal

    PiperJaffrey MarkArnold

    Sidoti&Co. Nick Halen

    SingularResearch Frank DiLorenzo

    Analyst

    Coverage:

    2010 2009

    SummaryFinancialResults:

    Recentprice(3/31/11)

    52WeekLow

    52WeekHigh

    50DayMovingAverageAverageVolume(3m)

    SharesOutstanding(12/31/10)

    Beta

    InstitutionalShareholder%

    $9.90

    $7.57

    $11.04

    $10.1820K

    11.8M

    0.6

    31%